[Digestive complications of phenylbutazone].
作者信息
PERLES L, ZARA M, CHIMENES H
出版信息
Rev Rhum Mal Osteoartic. 1953 May;20(5):419-21.
PMID:13101352
Abstract
摘要
相似文献
1
[Digestive complications of phenylbutazone].
Rev Rhum Mal Osteoartic. 1953 May;20(5):419-21.
2
Phenylbutazone.
Br Med J. 1953 Aug 1;2(4830):287. doi: 10.1136/bmj.2.4830.287.
3
HAZARDS of phenylbutazone treatment.
Lancet. 1953 Jun 20;1(6773):1236-7.
4
Agranulocytosis following phenylbutazone (Butazolidin).保泰松（布他唑立丁）所致粒细胞缺乏症
N Y State J Med. 1953 Jul 1;53(13):1577-8.
5
Deaths of two patients treated by phenylbutazone.两名使用保泰松治疗的患者死亡。
Br Med J. 1953 Mar 28;1(4812):711-2. doi: 10.1136/bmj.1.4812.711.
6
Multiple toxic effects of phenylbutazone; report of a fatal case.保泰松的多种毒性作用；一例死亡病例报告。
Br Med J. 1955 May 28;1(4925):1318-20. doi: 10.1136/bmj.1.4925.1318.
7
Peptic ulcer perforation following administration of phenylbutazone.服用保泰松后发生消化性溃疡穿孔。
J Am Med Assoc. 1953 May 2;152(1):28-30. doi: 10.1001/jama.1953.63690010004007d.
8
The anti-thyroid effect of phenylbutazone.
Lancet. 1955 Jul 23;269(6882):164-5. doi: 10.1016/s0140-6736(55)92734-3.
9
Agranulocytosis following phenylbutazone therapy.
J Am Med Assoc. 1953 Apr 11;151(15):1286-9. doi: 10.1001/jama.1953.02940150026006a.
10
Fatal agranulocytosis and gastric ulceration due to phenylbutazone.
Lancet. 1953 Jun 20;1(6773):1230-1. doi: 10.1016/s0140-6736(53)92260-0.
Zotero 插件